1. Home
  2. SMBK vs SAGE Comparison

SMBK vs SAGE Comparison

Compare SMBK & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMBK
  • SAGE
  • Stock Information
  • Founded
  • SMBK N/A
  • SAGE 2010
  • Country
  • SMBK United States
  • SAGE United States
  • Employees
  • SMBK N/A
  • SAGE N/A
  • Industry
  • SMBK Major Banks
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMBK Finance
  • SAGE Health Care
  • Exchange
  • SMBK Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • SMBK 494.2M
  • SAGE 462.2M
  • IPO Year
  • SMBK N/A
  • SAGE 2014
  • Fundamental
  • Price
  • SMBK $35.63
  • SAGE $6.28
  • Analyst Decision
  • SMBK Buy
  • SAGE Hold
  • Analyst Count
  • SMBK 5
  • SAGE 20
  • Target Price
  • SMBK $28.20
  • SAGE $12.89
  • AVG Volume (30 Days)
  • SMBK 70.2K
  • SAGE 766.2K
  • Earning Date
  • SMBK 10-21-2024
  • SAGE 10-29-2024
  • Dividend Yield
  • SMBK 0.90%
  • SAGE N/A
  • EPS Growth
  • SMBK N/A
  • SAGE N/A
  • EPS
  • SMBK 1.93
  • SAGE N/A
  • Revenue
  • SMBK $159,196,000.00
  • SAGE $106,399,000.00
  • Revenue This Year
  • SMBK N/A
  • SAGE N/A
  • Revenue Next Year
  • SMBK $12.25
  • SAGE $126.69
  • P/E Ratio
  • SMBK $18.46
  • SAGE N/A
  • Revenue Growth
  • SMBK 2.18
  • SAGE 837.60
  • 52 Week Low
  • SMBK $19.00
  • SAGE $5.64
  • 52 Week High
  • SMBK $37.72
  • SAGE $28.26
  • Technical
  • Relative Strength Index (RSI)
  • SMBK 69.39
  • SAGE 41.29
  • Support Level
  • SMBK $32.25
  • SAGE $5.64
  • Resistance Level
  • SMBK $37.72
  • SAGE $6.44
  • Average True Range (ATR)
  • SMBK 1.02
  • SAGE 0.52
  • MACD
  • SMBK 0.32
  • SAGE -0.15
  • Stochastic Oscillator
  • SMBK 72.40
  • SAGE 22.22

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: